Weekend therapy for the treatment of Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 93, Issue 5, 1998, Pages 737-742

  Tucci, Antonio ^a,b   Poli, Loris ^a   Paparo, G Francesco ^a   Bocus, Paolo ^a   Togliani, Thomas ^a   Mazzoni, Claudia ^a   Orcioni, Giulio Fraternali ^a   Agosti, Roberto ^a   Grigioni, Walter F ^a   Sottili, Sara ^a   Caletti, Giancarlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; OMEPRAZOLE; TINIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; DUODENUM ULCER; DYSPEPSIA; FEMALE; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; WEATHER;

ADULT; AGED; AMOXICILLIN; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; DYSPEPSIA; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; TINIDAZOLE;

EID: 0032081015     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.216_a.x     Document Type: Article

References (26)

1. 1. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997;11(suppl 1):71-88.
2. 2. De Boer WA, Driessen WMM, Potters HVPJ, et al. Randomized study comparing one with two weeks of quadruple therapy for eradicating H. pylori. Am J Gastroenterol 1994;89:1993-7.
3. 3. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short-term, low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993;104:A-10 (abstract).
4. 4. Harris A, Misiewicz JJ. Hitting H. pylori for four. Lancet 1995;345: 806-7.
5. 5. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
6. 6. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney system: A new classification of gastritis. World Congress on Gastroenterology. Working Party Reports. Sydney: Blackwell Science Publishing, 1990, 1-10.
7. 7. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992;103:768-74.
8. 8. Goodwin CS, Marshall BJ, Blincow ED, et al. Prevention of Nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies. J Clin Pathol 1988;41:207-10.
9. 9. O'Riordan T, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1991; 31:999-1002.
10. 10. Rauws EAJ. Therapeutic attempts at eradication of Campylobacter pylori. Eur J Gastroenterol Hepatol 1992;1:34-41.
11. 11. McNulty CA, Dent JC, Ford GA, et al. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988;22:729-38.
12. 12. Tsuji A, Nakashima E, Hamano S, et al. Physicochemical properties of amphoteric b-lactam antibiotics. I: stability, solubility, and dissolution behaviour of amino penicillins as a function of pH. J Pharmac Sci 1978;67:1059-65.
13. 13. Iwahi T, Satoh H, Nakoa M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compound have a selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-6.
14. 14. Bugnoli M, Bayelli PF, Rappuoli R, et al. Inhibition of Helicobacter pylori urease by omeprazole. Eur J Gastroenterol Hepathol 1993;5: 683-5.
15. 15. De Boer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345:817-20.
16. 16. Cederberg C, Thomson ABR, Mahachai V, et al. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology 1992;103:913-8.
17. 17. Tucci A, Corinaldesi R, Stanghellini V, et al. One-day therapy for the treatment of Helicobacter pylori infection. Dig Dis Sci 1993;38: 1670-3.
18. 18. Takats A, Racz I, Boga B, et al. Efficacy of a one day triple therapy with potentialisation of omeprazole for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1399 (abstract).
19. 19. Kimura K, Ido K, Saifuku K, et al. A 1-h topical therapy for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90:60-3.
20. 20. Burette A, Glupczynski Y, De Prez C. Evaluation of multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:817-23.
21. 21. De Boer WA, Van Etten RJXM, Schade RWB, et al. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:109-112.
22. 22. De Boer WA, Driessen WMM, Tytgat NJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:633-8.
23. 23. Catalano F, Branciforte G, Bentivegna C, et al. Duodenal ulcer and functional dyspepsia: Different susceptibility of Helicobacter pylori to eradicating therapy. Helicobacter 1997;2:106 (letter).
24. 24. Tucci A, Poli L, Gasperoni S, et al. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol 1994;26:107-10.
25. 25. Moshkowitz M, Konikoff FM, Arber N, et al. Seasonal variation in the frequency of Helicobacter pylori infection: A possible cause of the seasonal occurrence of peptic ulcer disease. Am J Gastroenterol 1994; 89:731-3.
26. 26. Zimmermann J, Amon R, Beeri R, et al. Seasonal fluctuation in acute upper gastrointestinal bleeding: Lack of effect of non-steroidal antiinflammatory drugs. Am J Gastroenterol 1992;87:1587-90.